liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Increased expression of specific thioredoxin family proteins; a pilot immunohistochemical study on human hepatocellular carcinoma
Department of Biosciences and Nutrition at NOVUM, Karolinska Institutet, Stockholm, Sweden.
Department of Laboratory Medicine, Pathology Division, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
Department of Laboratory Medicine, Pathology Division, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
Department of Laboratory Medicine, Pathology Division, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
Show others and affiliations
2007 (English)In: International journal of immunopathology and pharmacology, ISSN 0394-6320, Vol. 20, no 1, 17-24 p.Article in journal (Refereed) Published
Abstract [en]

Hepatocellular Carcinoma (HCC) is one of the most frequent cancers worldwide, however, prognosis remains poor following its discovery. We investigate the Thioredoxin superfamily of proteins as diagnostic markers for HCC. Furthermore, we delineate possible roles of the endoplasmic reticulum member of the superfamily, ERdj5, in carcinogenesis. Using antibodies against Thioredoxin 1, Thioredoxin Reductase 1 and ERdj5, we performed immunohistochemistry on paraffin embedded liver biopsy sections from HCC patients. All three redox proteins exhibited elevated expression levels in tumor tissue compared to internal control, with ERdj5 showing a remarkable 3-fold increase. In vitro cell viability experiments using Hepatocellular Carcinoma HuH7 cells treated with ERdj5 small interfering RNA showed that ERdj5 knockdown cells exhibited less resistance to Doxorubicin (chemotherapy drug), but more resistance to Tunicamycin (Endoplasmic Stress inducer), compared to control cells. In conclusion, we introduce members of the Thioredoxin superfamily as possible immunohistochemical markers in the diagnostics of hepatocellular carcinoma and indicate a potential defensive role for ERdj5 in chemotherapeutic drug resistance.

Place, publisher, year, edition, pages
Biolife , 2007. Vol. 20, no 1, 17-24 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-98711ISI: 000245120600003PubMedID: 17346424OAI: oai:DiVA.org:liu-98711DiVA: diva2:655528
Available from: 2013-10-11 Created: 2013-10-11 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text

Other links

PubMedLink to journal

Authority records BETA

Spyrou, Giannis

Search in DiVA

By author/editor
Spyrou, Giannis
In the same journal
International journal of immunopathology and pharmacology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 33 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf